Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
748.14
-2.13 (-0.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 6, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
394,614
Open
751.84
Bid (Size)
748.14 (13)
Ask (Size)
748.44 (1)
Prev. Close
750.27
Today's Range
745.42 - 754.50
52wk Range
538.01 - 837.55
Shares Outstanding
91,779,465
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Biotech Stocks to Sell in June Before They Crash and Burn
June 06, 2023
Investors should get out of these biotech stocks to sell now that the Covid-19 pandemic is largely over. These's worse in store for them.
Via
InvestorPlace
Regeneron Pharmaceuticals Unusual Options Activity For June 05
June 05, 2023
Via
Benzinga
Performance
YTD
+3.84%
+3.84%
1 Month
-0.53%
-0.53%
3 Month
-3.32%
-3.32%
6 Month
+0.09%
+0.09%
1 Year
+22.84%
+22.84%
More News
Read More
Wall Street Says These 2 Stocks May Double. Should You Buy Them?
June 05, 2023
Via
The Motley Fool
Regeneron Pharmaceuticals Unusual Options Activity
May 30, 2023
Via
Benzinga
Regeneron Reveals Updated Data From Multiple Myeloma Study, Showing Response Rate Of 71%
May 26, 2023
Via
Benzinga
Updated Linvoseltamab (BCMAxCD3) Data from Pivotal Trial Demonstrates Early, Deep and Durable Responses in Patients with Heavily Pre-treated Multiple Myeloma
May 25, 2023
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Regeneron Pharmaceuticals Unusual Options Activity For May 25
May 25, 2023
Via
Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
May 22, 2023
Via
Benzinga
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is a Leading Gainer in 5/19 Morning Trading
May 19, 2023
Via
Investor Brand Network
Fianlimab (LAG-3 inhibitor) Combined with Libtayo® (cemiplimab) Shows Clinically Meaningful and Durable Tumor Responses Across Key Advanced Melanoma Patient Populations
May 25, 2023
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
A Good Week For The Market But A Pause In The Biotech Rally
May 22, 2023
Via
Talk Markets
Sanofi-Regeneron Highlight Dupixent Data, Say Drug Benefit Was Swift, Sustained
May 22, 2023
Via
Benzinga
Dupixent® (dupilumab) Late-breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of Medicine
May 21, 2023
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
This Is What Whales Are Betting On Regeneron Pharmaceuticals
May 19, 2023
Via
Benzinga
How Is The Market Feeling About Regeneron Pharmaceuticals?
May 15, 2023
Via
Benzinga
Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity
May 08, 2023
Via
Benzinga
High School Scientists and Engineers Win Nearly $9 Million at the Regeneron International Science and Engineering Fair 2023
May 19, 2023
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Regeneron Announces Investor Conference Presentations
May 18, 2023
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Regeneron Applauds Supreme Court’s Unanimous Opinion Striking Down Amgen’s PCSK9 Patent Claims and Supporting Scientific Innovation
May 18, 2023
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
The 7 Growth Stocks You Need to Own Now for Maximum Returns
May 17, 2023
Via
InvestorPlace
AI-Run ETF Dumps Apple In Favor Of This Chip Stock And Hints At New Opportunity Brewing In Market
May 12, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 10, 2023
Via
Benzinga
2 Cathie Wood Stocks That Can Get You Through Any Recession
May 10, 2023
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
May 09, 2023
Via
Benzinga
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
May 05, 2023
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.